1-5 of 5
Amit Jain
Close
Sort by
Journal Articles

Safety and Efficacy of Letetresgene Autoleucel (lete-cel; GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma

Taiga Nishihori, James E. Hoffman, Jonathan L. Kaufman, Anne Huff, Charlotte Snape, Amit Jain, Gurpreet Kapoor, Stefan Zajic, Sunil Suchindran, Michael Chisamore, Aaron P. Rapoport
Journal: Blood
Blood (2021) 138 (Supplement 1): 3865.
https://doi.org/10.1182/blood-2021-153004
Published: 2021
Journal Articles

Open-Label Pilot Study of Genetically Engineered NY-ESO-1 Specific T Cells (GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma

Taiga Nishihori, MD, Jonathan L. Kaufman, MD, James E. Hoffman, Kristin Blouch, Sunil Pandit, Emily Butler, Amit Jain, Yuehui Wu, M. Phillip DeYoung, Aisha N. Hasan, Aaron P. Rapoport
Journal: Blood
Blood (2019) 134 (Supplement_1): 3134.
https://doi.org/10.1182/blood-2019-128059
Published: 2019
Journal Articles

Increased Use of Direct Thrombin Inhibitor Argatroban In Hospitalized Patients

Amit Jain, MD, Kristen Smit, Naveen Manchanda, MBBS
Journal: Blood
Blood (2010) 116 (21): 4398.
https://doi.org/10.1182/blood.V116.21.4398.4398
Published: 2010
Journal Articles

Outcome of Diffuse Alveolar Hemorrhage in Hematopoietic Stem Cell Transplant Recipients.

Sachin Gupta, MD, Amit Jain, MD, Aditya Gupta, MD, Carla L. Warneke, MS, Sergio Giralt, MD, Georgie A. Eapen, MD
Journal: Blood
Blood (2006) 108 (11): 2967.
https://doi.org/10.1182/blood.V108.11.2967.2967
Published: 2006
Journal Articles

Outcome of Recombinant Factor VIIa Use for Alveolar Hemorrhage in Hematopoietic Stem Cell Transplant Recipients.

Sachin Gupta, MD, Aditya Gupta, MD, Amit Jain, MD, Carla L. Warneke, MS, Sergio Giralt, MD, Georgie A. Eapen, MD
Journal: Blood
Blood (2006) 108 (11): 3997.
https://doi.org/10.1182/blood.V108.11.3997.3997
Published: 2006